Prevalence and Predictive Factors of Histopathological Complications in Children with Esophageal Atresia - PubMed (original) (raw)

. 2019 Dec;29(6):510-515.

doi: 10.1055/s-0038-1676505. Epub 2018 Dec 19.

Affiliations

• PMID: 30566986
• DOI: 10.1055/s-0038-1676505

Prevalence and Predictive Factors of Histopathological Complications in Children with Esophageal Atresia

Laetitia-Marie Petit et al. Eur J Pediatr Surg. 2019 Dec.

Abstract

Objectives: Endoscopic follow-up after esophageal atresia (EA) tracheoesophageal fistula (TEF) repair is recommended to detect esophageal histopathological complications. We investigated the prevalence of histopathologically proven esophageal complications (peptic esophagitis, gastric metaplasia, and eosinophilic esophagitis) and assessed the predictors of these complications in children with EA-TEF.

Materials and methods: This is a prospective longitudinal cohort study performed between September 2005 and December 2014 comprising 77 children with EA-TEF followed-up until February 2017. Univariate analysis was performed using the Wilcoxon's rank-sum test for continuous variables and the Pearson's chi-square test for categorical variables. Multivariable analysis was performed using a Cox regression hazard model. The association between clinical factors and histopathologically proven complications was estimated using a Cox regression hazard model with time until the appearance of complications as the time scale.

Results: All 77 children received proton pump inhibitors (PPIs) (n = 73) or H2 receptor antagonists (H2RA). A total of 252 endoscopies were performed in 73 children (median 2.6/child, range: 1-29). Median age at study completion was 4.9 years (range: 2.3-11.5 years). Histopathologically proven complications occurred in 38 children (52%): peptic esophagitis (n = 32, 44%), eosinophilic esophagitis (n = 15, 21%), and gastric metaplasia (n = 9, 12%). A total of 82% patients were on PPI or H2RA at the time of diagnosis of histological complication. Multivariable Cox regression analysis showed that patients with recurrent anastomotic strictures (>3 dilations) had a higher risk of occurrence of histopathologically proven complications over time (hazard ratio: 3.11, 95% confidence interval [CI]: 1.53-6.34). On univariate analysis, the result of the first endoscopy was not associated with the occurrence of histopathologically proven complications (odds ratio: 0.8, 95% CI: 0.16-3.95).

Conclusion: Histopathologically proven complications with potential long-term consequences occurred in approximately 50% of children after EA-TEF repair. A history of recurrent anastomotic strictures is associated with the occurrence of these complications. The result of the first endoscopy does not predict the histopathological outcome. Children with EA-TEF warrant close and systematic long-term follow-up at specialized multidisciplinary clinics with endoscopic evaluation.

Georg Thieme Verlag KG Stuttgart · New York.

PubMed Disclaimer

Conflict of interest statement

None declared.

Similar articles

• Should Proton Pump Inhibitors be Systematically Prescribed in Patients With Esophageal Atresia After Surgical Repair?
  Righini Grunder F, Petit LM, Ezri J, Jantchou P, Aspirot A, Laberge S, Faure C. Righini Grunder F, et al. J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):45-51. doi: 10.1097/MPG.0000000000002328. J Pediatr Gastroenterol Nutr. 2019. PMID: 30889131
• Esophagitis, treatment outcomes, and long-term follow-up in children with esophageal atresia.
  Bashir A, Krasaelap A, Lal DR, Gourlay DM, Pan AY, Jan N, McCord S, Lerner DG. Bashir A, et al. J Pediatr Gastroenterol Nutr. 2024 Dec;79(6):1116-1123. doi: 10.1002/jpn3.12386. Epub 2024 Oct 16. J Pediatr Gastroenterol Nutr. 2024. PMID: 39415542
• Postoperative Complications and Functional Outcome after Esophageal Atresia Repair: Results from Longitudinal Single-Center Follow-Up.
  Friedmacher F, Kroneis B, Huber-Zeyringer A, Schober P, Till H, Sauer H, Höllwarth ME. Friedmacher F, et al. J Gastrointest Surg. 2017 Jun;21(6):927-935. doi: 10.1007/s11605-017-3423-0. Epub 2017 Apr 19. J Gastrointest Surg. 2017. PMID: 28424985
• Motility, digestive and nutritional problems in Esophageal Atresia.
  Gottrand M, Michaud L, Sfeir R, Gottrand F. Gottrand M, et al. Paediatr Respir Rev. 2016 Jun;19:28-33. doi: 10.1016/j.prrv.2015.11.005. Epub 2015 Dec 4. Paediatr Respir Rev. 2016. PMID: 26752295 Review.
• Diagnosis and Management of Long-term Gastrointestinal Complications in Pediatric Esophageal Atresia/Tracheoesophageal Fistula.
  O'Shea D, Quinn E, Middlesworth W, Khlevner J. O'Shea D, et al. Curr Gastroenterol Rep. 2025 Feb 25;27(1):16. doi: 10.1007/s11894-025-00968-6. Curr Gastroenterol Rep. 2025. PMID: 39998690 Review.

Cited by

• Predictors of histopathological esophagitis in infants and adolescents with esophageal atresia within a national follow-up programme.
  Donoso F, Beckman A, Malinovschi A, Engstrand Lilja H. Donoso F, et al. PLoS One. 2022 Apr 15;17(4):e0266995. doi: 10.1371/journal.pone.0266995. eCollection 2022. PLoS One. 2022. PMID: 35427378 Free PMC article.
• Pharmacokinetic Evaluation of Oral Viscous Budesonide in Paediatric Patients with Eosinophilic Oesophagitis in Repaired Oesophageal Atresia.
  Simeoli R, Lava SAG, Di Deo A, Roversi M, Cairoli S, Tambucci R, Rea F, Malamisura M, Angelino G, Biondi I, Simonetti A, De Angelis P, Dionisi Vici C, Rossi P, Pontrelli G, Della Pasqua O, Goffredo BM. Simeoli R, et al. Pharmaceutics. 2024 Jun 28;16(7):872. doi: 10.3390/pharmaceutics16070872. Pharmaceutics. 2024. PMID: 39065569 Free PMC article.
• Clinical yield of esophagogastroduodenoscopy and pH-impedance testing in esophageal atresia patients performed according to international guidelines.
  van Lennep M, Mussies C, Benninga MA, Gorter RR, Krishnan U, van Wijk MP. van Lennep M, et al. Dis Esophagus. 2025 Jan 7;38(2):doaf022. doi: 10.1093/dote/doaf022. Dis Esophagus. 2025. PMID: 40178207 Free PMC article.
• Genetic Background of Eosinophilic Esophagitis and Esophageal Atresia in Children.
  Ulkersoy I, Colakoglu A, Pinar E, Kuduban E, Akkus E, Tin O, Kologlu Ates N, Khodzhaev K, Keskin Karakoyun H, Sayar C, Kepil N, Yararbas K, Beser OF, Cokugras H, Cullu Cokugras F. Ulkersoy I, et al. Dig Dis Sci. 2025 May 14. doi: 10.1007/s10620-025-09094-9. Online ahead of print. Dig Dis Sci. 2025. PMID: 40369394
• Eosinophilic esophagitis in esophageal atresia: Tertiary care experience of a "selective" approach for biopsy sampling.
  Tambucci R, Rea F, Angelino G, Malamisura M, Mennini M, Riccardi C, Farello G, Valfré L, Dall'Oglio L, Markowitz JE, Fiocchi AG, De Angelis P. Tambucci R, et al. World Allergy Organ J. 2020 Apr 2;13(4):100116. doi: 10.1016/j.waojou.2020.100116. eCollection 2020 Apr. World Allergy Organ J. 2020. PMID: 32256942 Free PMC article.

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources

• Full Text Sources

  • Georg Thieme Verlag Stuttgart, New York
  • Ovid Technologies, Inc.